Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Optimization of Cardiac Resynchronization Therapy: Should Perioperative Hemodynamic Measurements Be Routine?

Payne JE, Gold MR.

JACC Clin Electrophysiol. 2019 Sep;5(9):1026-1027. doi: 10.1016/j.jacep.2019.07.002. No abstract available.

PMID:
31537330
2.

Higher initial weight-based heparin dosing is required with direct oral anticoagulants during catheter ablation for atrial fibrillation.

Payne JE, Koerber SM, Bickel T, Ghadban R, Flaker G, Gautam S.

J Interv Card Electrophysiol. 2019 Jun 22. doi: 10.1007/s10840-019-00579-y. [Epub ahead of print]

PMID:
31230179
3.

Impact of Left Ventricular Hypertrophy on Peak Serum Troponin T Levels in Patients With Acute Myocardial Infarction.

Payne JE, Ghadban R, Loethen T, Boyle K, Alpert MA, Madsen R, Kumar SA.

Am J Cardiol. 2019 Jun 1;123(11):1745-1750. doi: 10.1016/j.amjcard.2019.02.044. Epub 2019 Mar 9.

PMID:
30935498
4.

A Substernal Defibrillator Lead With Pacing Capability: Another Tool in the Toolbox?

Payne JE, Gold MR.

JACC Clin Electrophysiol. 2019 Feb;5(2):197-198. doi: 10.1016/j.jacep.2018.12.006. No abstract available.

PMID:
30784690
5.

Multidisciplinary sarcoma care.

Pollock RE, Payne JE, Rogers AD, Smith SM, Iwenofu OH, Valerio IL, Zomerlei TA, Howard JH, Dornbos D 3rd, Galgano MA, Goulart C, Mendel E, Miller ED, Xu-Welliver M, Martin DD, Haglund KE, Bupathi M, Chen JL, Yeager ND.

Curr Probl Surg. 2018 Dec;55(12):517-580. doi: 10.1067/j.cpsurg.2018.10.006. Epub 2018 Nov 9. No abstract available.

PMID:
30526918
6.

Third-degree burns associated with transcutaneous pacing.

Payne JE, Morgan JL, Weachter RR, Alpert MA.

BMJ Case Rep. 2018 Oct 2;2018. pii: bcr-2018-226769. doi: 10.1136/bcr-2018-226769.

PMID:
30279263
7.

Activity of hypothiocyanite and lactoferrin (ALX-009) against respiratory cystic fibrosis pathogens in sputum.

Tunney MM, Payne JE, McGrath SJ, Einarsson GG, Ingram RJ, Gilpin DF, Juarez-Perez V, Elborn JS.

J Antimicrob Chemother. 2018 Dec 1;73(12):3391-3397. doi: 10.1093/jac/dky357.

PMID:
30219825
8.

Defining Adherence to Dietary Self-Monitoring Using a Mobile App: A Narrative Review.

Payne JE, Turk MT, Kalarchian MA, Pellegrini CA.

J Acad Nutr Diet. 2018 Nov;118(11):2094-2119. doi: 10.1016/j.jand.2018.05.011. Epub 2018 Aug 13. Review.

PMID:
30115555
9.

A QS pattern in leads V1 and V2 is associated with septal scarring independent of scar etiology - A cardiac magnetic resonance imaging study.

Ghadban R, Alpert MA, Dohrmann ML, Allaham H, Payne JE, Fong HK, Kumar SA.

J Electrocardiol. 2018 Jul - Aug;51(4):577-582. doi: 10.1016/j.jelectrocard.2018.03.011. Epub 2018 Mar 26.

PMID:
29996993
10.

Novel t(1;2)(p36.1;q23) and t(7;19)(q32;q13.3) chromosomal translocations in ischemic fasciitis: expanding the spectrum of pseudosarcomatous lesions with clonal pathogenetic link.

Sachak T, Heerema NA, Mayerson J, Payne JE, Parwani A, Iwenofu OH.

Diagn Pathol. 2018 Mar 2;13(1):18. doi: 10.1186/s13000-018-0695-y.

11.

Activity of innate antimicrobial peptides and ivacaftor against clinical cystic fibrosis respiratory pathogens.

Payne JE, Dubois AV, Ingram RJ, Weldon S, Taggart CC, Elborn JS, Tunney MM.

Int J Antimicrob Agents. 2017 Sep;50(3):427-435. doi: 10.1016/j.ijantimicag.2017.04.014. Epub 2017 Jun 27.

PMID:
28666755
12.

Immune modulatory nanoparticle therapeutics for intracerebral glioma.

Yaghi NK, Wei J, Hashimoto Y, Kong LY, Gabrusiewicz K, Nduom EK, Ling X, Huang N, Zhou S, Kerrigan BC, Levine JM, Fajt VR, Levine G, Porter BF, Marcusson EG, Tachikawa K, Chivukula P, Webb DC, Payne JE, Heimberger AB.

Neuro Oncol. 2017 Mar 1;19(3):372-382. doi: 10.1093/neuonc/now198.

13.

Massive localized lymphedema: a clinicopathologic study of 46 patients with an enrichment for multiplicity.

Kurt H, Arnold CA, Payne JE, Miller MJ, Skoracki RJ, Iwenofu OH.

Mod Pathol. 2016 Jan;29(1):75-82. doi: 10.1038/modpathol.2015.135. Epub 2015 Nov 20.

14.

Cortical representations sensitive to the number of perceived auditory objects emerge between 2 and 4 months of age: electrophysiological evidence.

Folland NA, Butler BE, Payne JE, Trainor LJ.

J Cogn Neurosci. 2015 May;27(5):1060-7. doi: 10.1162/jocn_a_00764. Epub 2014 Dec 1.

PMID:
25436670
15.

Cartilage imaging: a review of current concepts and emerging technologies.

Rogers AD, Payne JE, Yu JS.

Semin Roentgenol. 2013 Apr;48(2):148-57. doi: 10.1053/j.ro.2012.11.006. Review. No abstract available.

PMID:
23452462
16.

Pharmacological characterization of KLYP961, a dual inhibitor of inducible and neuronal nitric-oxide synthases.

Symons KT, Nguyen PM, Massari ME, Anzola JV, Staszewski LM, Wang L, Yazdani N, Dorow S, Muhammad J, Sablad M, Rozenkrants N, Bonefous C, Payne JE, Rix PJ, Shiau AK, Noble SA, Smith ND, Hassig CA, Zhang Y, Rao TS.

J Pharmacol Exp Ther. 2011 Feb;336(2):468-78. doi: 10.1124/jpet.110.172817. Epub 2010 Oct 29.

PMID:
21036913
17.
18.

Discovery of inducible nitric oxide synthase (iNOS) inhibitor development candidate KD7332, part 1: Identification of a novel, potent, and selective series of quinolinone iNOS dimerization inhibitors that are orally active in rodent pain models.

Bonnefous C, Payne JE, Roppe J, Zhuang H, Chen X, Symons KT, Nguyen PM, Sablad M, Rozenkrants N, Zhang Y, Wang L, Severance D, Walsh JP, Yazdani N, Shiau AK, Noble SA, Rix P, Rao TS, Hassig CA, Smith ND.

J Med Chem. 2009 May 14;52(9):3047-62. doi: 10.1021/jm900173b.

PMID:
19374401
19.

KLYP956 is a non-imidazole-based orally active inhibitor of nitric-oxide synthase dimerization.

Symons KT, Massari ME, Nguyen PM, Lee TT, Roppe J, Bonnefous C, Payne JE, Smith ND, Noble SA, Sablad M, Rozenkrants N, Zhang Y, Rao TS, Shiau AK, Hassig CA.

Mol Pharmacol. 2009 Jul;76(1):153-62. doi: 10.1124/mol.109.055434. Epub 2009 Apr 13.

PMID:
19364813
20.

Identification of KD5170: a novel mercaptoketone-based histone deacetylase inhibitor.

Payne JE, Bonnefous C, Hassig CA, Symons KT, Guo X, Nguyen PM, Annable T, Wash PL, Hoffman TZ, Rao TS, Shiau AK, Malecha JW, Noble SA, Hager JH, Smith ND.

Bioorg Med Chem Lett. 2008 Dec 1;18(23):6093-6. doi: 10.1016/j.bmcl.2008.10.029. Epub 2008 Oct 11.

PMID:
18954983
21.

KD5170, a novel mercaptoketone-based histone deacetylase inhibitor, exerts antimyeloma effects by DNA damage and mitochondrial signaling.

Feng R, Ma H, Hassig CA, Payne JE, Smith ND, Mapara MY, Hager JH, Lentzsch S.

Mol Cancer Ther. 2008 Jun;7(6):1494-505. doi: 10.1158/1535-7163.MCT-08-0183.

22.

KD5170, a novel mercaptoketone-based histone deacetylase inhibitor that exhibits broad spectrum antitumor activity in vitro and in vivo.

Hassig CA, Symons KT, Guo X, Nguyen PM, Annable T, Wash PL, Payne JE, Jenkins DA, Bonnefous C, Trotter C, Wang Y, Anzola JV, Milkova EL, Hoffman TZ, Dozier SJ, Wiley BM, Saven A, Malecha JW, Davis RL, Muhammad J, Shiau AK, Noble SA, Rao TS, Smith ND, Hager JH.

Mol Cancer Ther. 2008 May;7(5):1054-65. doi: 10.1158/1535-7163.MCT-07-2347.

23.

"Failure to thrive" or failure to use the right growth chart?

Radcliffe B, Payne JE, Porteous H, Johnston SG.

Med J Aust. 2007 Jun 18;186(12):660-1. No abstract available.

PMID:
17576188
24.
25.

Novel approach to pro-drugs of lactones: water soluble imidate and ortho-ester derivatives of a furanone-based COX-2 selective inhibitor.

Poon SF, Stock N, Payne JE, McGuire AR, Stearns B, Yang X, Chen W, Munoz B, Smith ND.

Bioorg Med Chem Lett. 2005 May 2;15(9):2259-63.

PMID:
15837305
26.

Population and economic growth: a cointegration analysis of lesser developed countries.

Payne JE, Ewing BT.

Appl Econ Lett. 1997 Nov;4(11):665-9.

PMID:
12348722
27.
28.

A dose-ranging study of fluticasone propionate administered once daily via multidose powder inhaler to patients with moderate asthma.

Nathan RA, Li JT, Finn A, Jones R, Payne JE, Wolford JP, Harding SM.

Chest. 2000 Aug;118(2):296-302.

PMID:
10936116
29.
30.

An evaluation of increasing doses of ranitidine for treatment of heartburn.

Pappa KA, Buaron K, Payne JE, Sirgo MA, Giefer EE.

Aliment Pharmacol Ther. 1999 Apr;13(4):475-81.

31.

A double-blind, placebo-controlled study of the efficacy and safety of non-prescription ranitidine 75 mg in the prevention of meal-induced heartburn.

Pappa KA, Williams BO, Payne JE, Buaron KS, Mussari KL, Ciociola AA.

Aliment Pharmacol Ther. 1999 Apr;13(4):467-73.

32.

Low-dose ranitidine for the relief of heartburn.

Pappa KA, Gooch WM, Buaron K, Payne JE, Giefer EE, Sirgo MA, Ciociola AA.

Aliment Pharmacol Ther. 1999 Apr;13(4):459-65.

33.

Independently predictive prognostic variables after resection for colorectal carcinoma.

Payne JE, Meyer HJ.

Aust N Z J Surg. 1997 Dec;67(12):849-53.

PMID:
9451339
34.

The influence of other diseases upon the outcome of colorectal cancer patients.

Payne JE, Meyer HJ.

Aust N Z J Surg. 1995 Jun;65(6):398-402.

PMID:
7786262
35.

Antimicrobial therapy in selected surgical patients.

Smith JM, Payne JE.

Aust N Z J Surg. 1994 Oct;64(10):658-66. Review. No abstract available.

PMID:
7945060
36.
37.

Carnitine deficiency associated with long-term pivampicillin treatment: the effect of a replacement therapy regime.

Rose SJ, Stokes TC, Patel S, Cooper MB, Betteridge DJ, Payne JE.

Postgrad Med J. 1992 Nov;68(805):932-4.

38.

Six week safety study of 2% MK-927 administered twice daily to ocular hypertensive volunteers.

Serle JB, Lustgarten J, Lippa EA, Camras CB, Framm L, Payne JE, Deasy D, Podos SM.

J Ocul Pharmacol. 1992 Spring;8(1):1-9.

PMID:
1402291
39.

Effects of Furegrelate (Upjohn 63557A) on patency and platelet deposition after canine carotid endarterectomy.

Payne JE, Langsfeld M, Joseph M, Huber D, Gray-Weale A, Meyer JH, Smith T, Lusby RJ.

Aust N Z J Surg. 1991 Aug;61(8):619-25.

PMID:
1867616
40.

Colorectal carcinogenesis.

Payne JE.

Aust N Z J Surg. 1990 Jan;60(1):11-8. Review.

PMID:
2183744
41.

Reduction in amputation stump infection by antiseptic pre-operative preparation.

Payne JE, Breust M, Bradbury R.

Aust N Z J Surg. 1989 Aug;59(8):637-40.

PMID:
2669718
42.

International colorectal carcinoma staging and grading.

Payne JE.

Dis Colon Rectum. 1989 Apr;32(4):282-5.

PMID:
2924668
43.

Symptoms and the diagnosis of bowel cancer: a critical view.

Payne JE.

Med J Aust. 1988 May 16;148(10):505-7. Review. No abstract available.

PMID:
3285152
44.

The cost of resection for colorectal cancer.

Payne JE, Murdoch CW, Dent OF, Chapuis PH.

Aust N Z J Surg. 1987 Sep;57(9):627-33.

PMID:
3689251
45.

Surgery for large bowel cancer in people aged 75 years and older.

Payne JE, Chapuis PH, Pheils MT.

Dis Colon Rectum. 1986 Nov;29(11):733-7.

PMID:
3769688
47.
48.

Overwhelming trauma.

Wiedeman JE, Payne JE Jr.

Mil Med. 1985 Dec;150(12):648-51. No abstract available.

PMID:
3935968
49.

Patient selection for adjuvant therapy trials in colorectal carcinoma.

Payne JE.

Aust N Z J Surg. 1985 Dec;55(6):593-7.

PMID:
3868999
50.

Professional and public education about bowel cancer.

Payne JE.

Med J Aust. 1985 Mar 18;142(6):338-9. No abstract available.

PMID:
3974505

Supplemental Content

Loading ...
Support Center